There is always the option of selling Diagnostics for around +$600m, paying off all the debt, then the medical centres and pathology divisions trade debt free, if the profit growth story is right, would be north of $2.5bn, all up, at least 20% more than the bid price.
Jangho kicks HLS Board where it hurts, page-5
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.035(2.66%) |
Mkt cap ! $1.212B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.36 | $1.33 | $1.778M | 1.321M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6637 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.35 | 6178 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| HLS (ASX) Chart |
